Fields »
ABOUT
HELP
BLOG

205 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 5 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
CR2Complement component (3d/Epstein Barr virus) receptor 2
Breast cancer: 6.90e-4
Group enriched22appendix:70.8
lymph node:207.6
spleen:101.3
tonsil:159.4
FAM129CFamily with sequence similarity 129, member C
Group enriched15appendix:14.5
bone marrow:11.3
lymph node:28.5
spleen:37.6
tonsil:9.7
MS4A1Membrane-spanning 4-domains, subfamily A, member 1
Breast cancer: 4.34e-5
Group enriched15appendix:249.3
lymph node:780.6
spleen:476.2
tonsil:821.5
FCRL3Fc receptor-like 3
Group enriched12appendix:18.8
lymph node:56.6
spleen:37.3
tonsil:33.6
AICDAActivation-induced cytidine deaminase
Group enriched11appendix:5.1
lymph node:18.9
tonsil:11.5
CD19CD19 molecule
Group enriched11appendix:38.8
lymph node:85.0
spleen:48.2
tonsil:70.8
BLKBLK proto-oncogene, Src family tyrosine kinase
Group enriched10appendix:22.9
lymph node:61.9
spleen:41.3
tonsil:54.0
CLEC17AC-type lectin domain family 17, member A
Group enriched10appendix:17.3
lymph node:30.8
spleen:19.8
tonsil:29.7
FCRLAFc receptor-like A
Group enriched10appendix:32.5
lymph node:81.6
spleen:57.4
tonsil:90.1
P2RX5Purinergic receptor P2X, ligand gated ion channel, 5
CytosolGroup enriched10appendix:42.6
lymph node:90.9
spleen:75.5
tonsil:48.4
SERPINA9Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
Group enriched10appendix:17.7
lymph node:51.0
tonsil:68.9
TNFRSF13CTumor necrosis factor receptor superfamily, member 13C
NucleusCervical cancer: 4.44e-7
Group enriched10appendix:23.8
lymph node:46.7
spleen:44.4
tonsil:51.9
CHRDL2Chordin-like 2
MitochondriaUrothelial cancer: 6.08e-4
Group enriched9appendix:162.3
endometrium:128.0
gallbladder:169.0
smooth muscle:181.2
urinary bladder:45.0
MCEMP1Mast cell-expressed membrane protein 1
Group enriched9appendix:28.5
bone marrow:43.9
lung:110.4
MEF2BMyocyte enhancer factor 2B
Group enriched9appendix:18.2
lymph node:46.3
tonsil:28.2
CCL7Chemokine (C-C motif) ligand 7
Group enriched8appendix:3.6
bone marrow:15.3
CD72CD72 molecule
Nucleus
Mitochondria		Renal cancer: 2.49e-8
Group enriched8appendix:26.2
lymph node:72.0
spleen:65.9
tonsil:44.3
FCRL2Fc receptor-like 2
Group enriched8appendix:16.9
lymph node:28.7
spleen:26.3
tonsil:24.6
LTBLymphotoxin beta (TNF superfamily, member 3)
CentrosomeRenal cancer: 3.31e-7
Endometrial cancer: 2.36e-6
Head and neck cancer: 1.74e-4
Group enriched8appendix:19.4
lymph node:22.5
spleen:26.4
tonsil:10.6
BTLAB and T lymphocyte associated
Group enriched7appendix:14.7
lymph node:29.6
spleen:14.8
tonsil:25.7
CNR2Cannabinoid receptor 2 (macrophage)
Group enriched7appendix:3.2
lymph node:8.8
spleen:8.1
tonsil:7.2
CXCL13Chemokine (C-X-C motif) ligand 13
Renal cancer: 1.16e-10
Ovarian cancer: 5.41e-4
Endometrial cancer: 5.52e-4
Colorectal cancer: 9.12e-4
Group enriched7appendix:170.3
lymph node:606.7
spleen:430.3
tonsil:411.9
FCER2Fc fragment of IgE, low affinity II, receptor for (CD23)
Group enriched7appendix:22.9
lymph node:48.1
spleen:53.7
tonsil:39.4
TLR10Toll-like receptor 10
Group enriched7appendix:22.0
lymph node:52.3
spleen:35.2
tonsil:46.8
CASP5Caspase 5, apoptosis-related cysteine peptidase
Group enriched6appendix:20.7
colon:16.2
duodenum:10.4
rectum:14.7
small intestine:19.3
CCR7Chemokine (C-C motif) receptor 7
MitochondriaHead and neck cancer: 7.61e-7
Cervical cancer: 8.03e-6
Breast cancer: 3.84e-4
Testis cancer: 7.72e-4
Group enriched6appendix:91.9
lymph node:98.3
spleen:39.9
tonsil:80.2
CCR9Chemokine (C-C motif) receptor 9
Group enriched6appendix:1.5
duodenum:3.9
small intestine:5.8
spleen:1.2
CD79ACD79a molecule, immunoglobulin-associated alpha
Head and neck cancer: 1.18e-5
Renal cancer: 2.15e-5
Breast cancer: 8.45e-5
Group enriched6appendix:275.4
lymph node:522.9
spleen:324.4
tonsil:440.3
CEACAM4Carcinoembryonic antigen-related cell adhesion molecule 4
Group enriched6appendix:6.8
bone marrow:14.0
spleen:9.1
CLEC4DC-type lectin domain family 4, member D
Group enriched6appendix:10.7
bone marrow:42.9
IRG1Immunoresponsive 1 homolog (mouse)N/A
Tissue enriched6appendix:2.0
LILRB3Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3
Group enriched6adipose tissue:5.3
appendix:10.4
bone marrow:8.3
lung:8.7
spleen:9.4
urinary bladder:6.9
OLR1Oxidized low density lipoprotein (lectin-like) receptor 1
Nucleoplasm
Vesicles
Plasma membrane		Head and neck cancer: 8.24e-5
Group enriched6appendix:42.1
cerebral cortex:32.8
lung:146.2
placenta:159.6
POU2F2POU class 2 homeobox 2
NucleoplasmRenal cancer: 7.57e-11
Group enriched6appendix:37.8
lymph node:62.5
spleen:37.2
tonsil:45.5
RGS13Regulator of G-protein signaling 13
Group enriched6appendix:14.8
lymph node:69.2
tonsil:38.3
SP140SP140 nuclear body protein
Nucleoli fibrillar center
Mitochondria		Group enriched6appendix:34.0
lymph node:65.2
spleen:38.9
tonsil:52.9
SRGNSerglycin
Renal cancer: 3.18e-5
Group enriched6appendix:1146.8
bone marrow:5150.0
STAP1Signal transducing adaptor family member 1
Nucleoplasm
Vesicles		Group enriched6appendix:24.7
kidney:13.1
lymph node:60.3
spleen:27.0
tonsil:58.9
TMEM156Transmembrane protein 156
Breast cancer: 4.09e-4
Group enriched6appendix:12.2
lymph node:28.1
spleen:15.4
tonsil:25.3
urinary bladder:5.9
TNFRSF6BTumor necrosis factor receptor superfamily, member 6b, decoy
Tissue enriched6appendix:19.6
AC018755.18
Group enriched5appendix:7.3
bone marrow:14.2
lymph node:3.6
spleen:5.0
ADGRG3Adhesion G protein-coupled receptor G3N/A
Group enriched5appendix:19.4
bone marrow:86.7
BANK1B-cell scaffold protein with ankyrin repeats 1
Nucleoplasm
Plasma membrane
Cytosol		Group enriched5appendix:47.6
lymph node:97.9
spleen:78.5
thyroid gland:21.5
tonsil:90.9
CCL19Chemokine (C-C motif) ligand 19
Renal cancer: 8.63e-7
Cervical cancer: 9.91e-6
Breast cancer: 2.88e-5
Group enriched5adipose tissue:171.7
appendix:807.5
lymph node:715.5
tonsil:578.1
CD79BCD79b molecule, immunoglobulin-associated beta
Nucleoplasm
Plasma membrane
Cytosol		Head and neck cancer: 2.35e-4
Group enriched5appendix:94.7
lymph node:315.6
spleen:160.3
tonsil:196.1
FCN1Ficolin (collagen/fibrinogen domain containing) 1
Renal cancer: 3.98e-4
Group enriched5appendix:331.6
bone marrow:635.8
FCRL4Fc receptor-like 4
Group enriched5appendix:3.7
lymph node:4.5
tonsil:10.1
HTR3A5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
Endometrial cancer: 1.26e-4
Cervical cancer: 6.26e-4
Group enriched5appendix:2.9
lymph node:7.9
tonsil:7.4
IL24Interleukin 24
Breast cancer: 5.09e-4
Group enriched5appendix:17.9
lymph node:37.6
spleen:30.0
tonsil:28.5
LIMD2LIM domain containing 2
VesiclesRenal cancer: 5.36e-11
Group enriched5appendix:145.1
bone marrow:71.3
lymph node:259.7
spleen:195.3
tonsil:145.7

Page of 5 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.